PIMJETMI® (pimicotinib) Developed by Abbisko Therapeutics and Licensed by Merck KGaA, Darmstadt, Germany Receive U.S. FDA Approval for TGCT PIMJETMI® (pimicotinib) is a new systemic treatment option for certain U.S. adult… CISION PRNewswireNovember 11, 2026
PIMJETMI® (pimicotinib) Developed by Abbisko Therapeutics and Licensed by Merck KGaA, Darmstadt, Germany Receive U.S. FDA Approval for TGCT PIMJETMI® (pimicotinib) is a new systemic treatment option for certain U.S. adult… CISION PRNewswireNovember 11, 2026
Guardant360® Tissue Receives MOHW LDTS approval in Taiwan Approval paves the way for possible reimbursement coverage in future TAIPEI, Nov.… CISION PRNewswireNovember 11, 2026
Dingdong to Report Third Quarter 2026 Financial Results on November 12, 2026 SHANGHAI, Nov. 11, 2026 /PRNewswire/ — Dingdong (Cayman) Limited ("Dingdong" or the "Company")… CISION PRNewswireNovember 11, 2026
Guardant360® Tissue Receives MOHW LDTS approval in Taiwan Approval paves the way for possible reimbursement coverage in future TAIPEI, Nov.… CISION PRNewswireNovember 11, 2026
Dingdong to Report Third Quarter 2026 Financial Results on November 12, 2026 SHANGHAI, Nov. 11, 2026 /PRNewswire/ — Dingdong (Cayman) Limited ("Dingdong" or the "Company")… CISION PRNewswireNovember 11, 2026
Xinhua Silk Road: 7th Luban Cultural Festival and Mozi-Luban Academic Symposium launched in Tengzhou, Shandong BEIJING, Nov. 11, 2026 /PRNewswire/ — The 7th Luban Cultural Festival and Mozi-Luban… CISION PRNewswireNovember 11, 2026
Xinhua Silk Road: 7th Luban Cultural Festival and Mozi-Luban Academic Symposium launched in Tengzhou, Shandong BEIJING, Nov. 11, 2026 /PRNewswire/ — The 7th Luban Cultural Festival and Mozi-Luban… CISION PRNewswireNovember 11, 2026
